- Correspondence to Dr Stefanie Thevelin, Université catholique de Louvain Louvain Drug Research Institute, Bruxelles 1200, Belgium;
- Received October 31, 2021
- Accepted February 24, 2022
- First published March 29, 2022.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.